FRMD8 Activators
FRMD8 can influence its activity through various intracellular signaling pathways. Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioctanoyl-sn-glycerol function as diacylglycerol (DAG) analogs, activating protein kinase C (PKC). The activation of PKC can result in the phosphorylation of numerous proteins, including those involved in the organization of the cytoskeleton, where FRMD8 plays a role. This suggests that these compounds can contribute to the activation of FRMD8 by promoting the PKC-mediated phosphorylation pathway. Similarly, Forskolin, by increasing intracellular cyclic AMP (cAMP) levels, activates protein kinase A (PKA), which can phosphorylate various proteins that may modulate the activity of FRMD8, particularly in pathways related to cell adhesion and morphology.
Ionomycin, by increasing intracellular calcium levels, can activate calmodulin-dependent kinases, which in turn can phosphorylate proteins involved in cytoskeletal organization and potentially activate FRMD8 as part of the cellular response to elevated calcium levels. The activation of the MAPK/ERK pathway through the action of Epidermal Growth Factor (EGF) can also lead to the activation of FRMD8, as this pathway is known to regulate proteins involved in cell adhesion and motility. Inhibitors such as Calyculin A and Okadaic Acid, which prevent the dephosphorylation of proteins by inhibiting protein phosphatases 1 and 2A, can lead to indirect activation of FRMD8 by maintaining or enhancing its phosphorylated state. Anisomycin, a protein synthesis inhibitor, can activate stress-activated protein kinases like JNK, which might phosphorylate and activate scaffold proteins including FRMD8. Additionally, Thapsigargin, through its role in increasing cytosolic calcium levels, and phosphatidic acid, via the activation of mTOR signaling, can contribute to the regulation of cytoskeletal dynamics, with potential implications for FRMD8 activity. Lastly, Bisindolylmaleimide I, although typically a PKC inhibitor, can under certain conditions mimic DAG and activate PKC, which may result in the activation of FRMD8 through PKC-dependent phosphorylation pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol esters like PMA act as diacylglycerol (DAG) mimetics, activating protein kinase C (PKC), which is known to phosphorylate and activate a myriad of proteins, including those involved in cytoskeletal organization where FRMD8 is implicated. Activation of PKC can lead to downstream activation of proteins associated with actin-binding and cellular structure. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore which increases intracellular calcium levels, thereby activating calmodulin-dependent kinase (CaMK), which can phosphorylate proteins involved with the actin cytoskeleton and potentially lead to the activation of FRMD8 as part of the cellular response to altered calcium levels. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
This synthetic analog of diacylglycerol (DAG) activates PKC, which can phosphorylate proteins in the actin cytoskeleton network. As FRMD8 is involved in cytoskeletal organization, DAG analogs could lead to the activation of FRMD8 through PKC-mediated signaling pathways. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), leading to increased phosphorylation levels of proteins. By inhibiting dephosphorylation, it can cause the indirect activation of FRMD8 if it is regulated by PP1 or PP2A. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic Acid inhibits PP1 and PP2A, potentially leading to the activation of FRMD8 by preventing its dephosphorylation, assuming FRMD8 activity is modulated by phosphorylation status. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases (SAPKs) such as JNK. Activation of JNK can result in the phosphorylation and activation of scaffold proteins like FRMD8 that are implicated in linking cellular signaling to the cytoskeleton. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor which leads to increased cytosolic calcium levels, potentially activating proteins like FRMD8 through calcium-dependent signaling pathways that regulate cytoskeletal dynamics. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a selective inhibitor of PKC, but it can also serve as an activator under certain conditions by binding to the active site and mimicking DAG. If FRMD8 is a PKC substrate, Bisindolylmaleimide I could activate it by promoting PKC-mediated phosphorylation in a non-classical way. | ||||||